Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

BillionToOne, Inc.

BLLNNASDAQ
Healthcare
Medical - Diagnostics & Research
$69.11
$5.08(7.93%)
U.S. Market opens in 11h 48m

BillionToOne, Inc. Fundamental Analysis

BillionToOne, Inc. (BLLN) shows weak financial fundamentals with a PE ratio of 949.78, profit margin of 1.07%, and ROE of 1.30%. The company generates $0.3B in annual revenue with weak year-over-year growth of 1.13%.

Key Strengths

Cash Position15.67%
Current Ratio11.69

Areas of Concern

ROE1.30%
Operating Margin5.25%
PEG Ratio8.55
We analyze BLLN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 50.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
50.3/100

We analyze BLLN's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLLN struggles to generate sufficient returns from assets.

ROA > 10%
0.51%

Valuation Score

Weak

BLLN trades at a premium to fair value.

PE < 25
949.78
PEG Ratio < 2
8.55

Growth Score

Moderate

BLLN shows steady but slowing expansion.

Revenue Growth > 5%
1.13%
EPS Growth > 10%
49.73%

Financial Health Score

Excellent

BLLN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.23
Current Ratio > 1
11.69

Profitability Score

Moderate

BLLN maintains healthy but balanced margins.

ROE > 15%
130.19%
Net Margin ≥ 15%
1.07%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BLLN Expensive or Cheap?

P/E Ratio

BLLN trades at 949.78 times earnings. This suggests a premium valuation.

949.78

PEG Ratio

When adjusting for growth, BLLN's PEG of 8.55 indicates potential overvaluation.

8.55

Price to Book

The market values BillionToOne, Inc. at 6.43 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.43

EV/EBITDA

Enterprise value stands at 189.02 times EBITDA. This signals the market has high growth expectations.

189.02

How Well Does BLLN Make Money?

Net Profit Margin

For every $100 in sales, BillionToOne, Inc. keeps $1.07 as profit after all expenses.

1.07%

Operating Margin

Core operations generate 5.25 in profit for every $100 in revenue, before interest and taxes.

5.25%

ROE

Management delivers $1.30 in profit for every $100 of shareholder equity.

1.30%

ROA

BillionToOne, Inc. generates $0.51 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.51%

Following the Money - Real Cash Generation

Operating Cash Flow

BillionToOne, Inc. generates limited operating cash flow of $24.60M, signaling weaker underlying cash strength.

$24.60M

Free Cash Flow

BillionToOne, Inc. produces free cash flow of $15.71M, offering steady but limited capital for shareholder returns and expansion.

$15.71M

FCF Per Share

Each share generates $0.34 in free cash annually.

$0.34

FCF Yield

BLLN converts 0.51% of its market value into free cash.

0.51%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

949.78

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

8.55

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.43

vs 25 benchmark

P/S Ratio

Price to sales ratio

10.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

11.69

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.01

vs 25 benchmark

ROA

Return on assets percentage

0.005

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How BLLN Stacks Against Its Sector Peers

MetricBLLN ValueSector AveragePerformance
P/E Ratio949.7828.25 Worse (Expensive)
ROE1.30%780.00% Weak
Net Margin1.07%-20122.00% (disorted) Weak
Debt/Equity0.230.30 Strong (Low Leverage)
Current Ratio11.694.66 Strong Liquidity
ROA0.51%-14687.00% (disorted) Weak

BLLN outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews BillionToOne, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

112.72%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

49.72%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

22.91%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ